Company / EPS (Diluted)
BioAtla, Inc. EPS (Diluted) History
FY2021-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$2.76
FY2022
5-year range
-$3.19 / -$2.76
FY2021-FY2022
Trend
+13.5%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-2.76 in FY2022.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, eps (diluted) increased 13.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.29 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$2.76 | +13.5% |
| FY2021 | -$3.19 | - |
As of FY2022 · SEC Form 10-K · Last checked Jun 21, 2026